Publication Results (43)

• «
• 1
• 2
• »

• Osteoporosis guidelines

  Laupacis A. CMAJ. 2003; 168(13):1644-5.

• Adherence to osteoporosis pharmacotherapy is underestimated using days supply values in electronic pharmacy claims data

  Burden AM, Paterson JM, Gruneir A, Cadarette SM. Pharmacoepidemiol Drug Saf. 2015; 24(1):67-74. Epub 2014 Oct 21.

• Osteoporosis quality indicators using healthcare utilization data

  Cadarette SM, Jaglal SB, Raman-Wilms L, Beaton DE, Paterson JM. Osteoporos Int. 2011; 22(5):1335-42. Epub 2010 Jun 25.

• Variation in the days supply field for osteoporosis medications in Ontario

  Burden AM, Huang A, Tadrous M, Cadarette SM. Arch Osteoporos. 2013; 8:128. Epub 2013 Mar 9.

• Screening for osteoporosis in men receiving androgen deprivation therapy

  Alibhai SM, Yun L, Cheung AM, Paszat L. JAMA. 2012; 307(3):255-6.

• Osteoporosis management and fractures in the Métis of Ontario, Canada

  Jandoc R, Jembere N, Khan S, Russell SJ, Allard Y, Cadarette SM. Arch Osteoporos. Epub 2015 Apr 25.

• Using multiple data features improved the validity of osteoporosis case ascertainment from administrative databases

  Lix LM, Yogendran MS, Leslie WD, Shaw SY, Baumgartner R, Bowman C, Metge C, Gumel A, Hux J, James RC. J Clin Epidemiol. 2008; 61(12):1250-60. Epub 2008 Jul 10.

• Osteoporosis prescribing trends in primary care: a population-based retrospective cohort study

  Wang L, Tracy CS, Moineddin R, Upshur RE. Prim Health Care Res Dev. 2013; 14(1):1-6. Epub 2012 Apr 23.

• Glucocorticoid-induced osteoporosis management among seniors, by year, sex, and indication, 1996–2012

  Albaum JM, Levesque LE, Gershon AS, Liu G, Cadarette SM. Osteoporos Int. 2015; 26(12):2845-52. Epub 2015 Jul 3.

• How are family physicians managing osteoporosis? Qualitative study of their experiences and educational needs

  Jaglal SB, Carroll J, Hawker G, McIsaac WJ, Jaakkimainen L, Cadarette SM, Cameron C, Davis D. Can Fam Physician. 2003; 49(4):462-8.

• Screening and treatment for osteoporosis after stroke: results from the Ontario stroke registry

  Kapoor E, Austin PC, Alibhai SMH, Cheung AM, Cram P, Casaubon LK, Fang J, Porter J, Smith EE, Prager M, Kapral MK. Stroke. 2019; 50(6):1564-6. Epub 2019 Apr 25. DOI: 10.1161/STROKEAHA.118.024685.

• A population-based study of the risk of osteoporosis and fracture with dutasteride and finasteride

  Antoniou T, Macdonald EM, Yao Z, Gomes T, Tadrous M, Ho JM, Mamdani MM, Juurlink DN; Canadian Drug Safety and Effectiveness Research Network. BMC Musculoskelet Disord. 2018; 19:160. Epub 2018 May 22.

• Osteoporosis medication prescribing in British Columbia and Ontario: impact of public drug coverage

  Cadarette SM, Carney G, Baek D, Gunraj N, Paterson JM, Dormuth CR. Osteoporos Int. 2011; 23(4):1475-80. Epub 2011 Sep 8.

• Improvements in osteoporosis testing and care are found following the wide scale implementation of the Ontario Fracture Clinic Screening Program: an interrupted time series analysis

  Beaton DE, Mamdani M, Zheng H, Jaglal S, Cadarette SM, Bogoch ER, Sale JEM, Sujic R, Jain R. Medicine. 2017; 96(48):e9012.

• Time trends in oral bisphosphonate initiation in Ontario, Canada over 20 years reflect drug policy and healthcare delivery changes

  Hayes KN, Ban JK, Athanasiadis G, Burden AM, Cadarette SM. Osteoporos Int. 2019; 30(11):2311-9. Epub 2019 Jul 17. DOI: https://doi.org/10.1007/s00198-019-05061-z.

• March 2011

  • Heart attack patients with depression less likely to receive priority care in emergency rooms
  • Long-term use of osteoporosis drugs linked to rare fractures of the thigh bone
  • Painkiller prescribing rates and outcomes vary among Ontario family physicians
  • Study finds significant variation in rates of lung cancer incidence and surgical care in Ontario
  • Majority of colonoscopy-related adverse events detectable within 14 days of procedure

• July/August 2005

  • Trauma injury risk is higher in summer for pregnant women
  • Population-based study demonstrates striking seasonality of croup hospitalizations in Ontario
  • Osteoporosis diagnosis and testing improvements reducing fracture rates in the elderly
  • Stroke-on-awakening and stroke-while-awake patients have similar outcomes
  • Valproate and lithium cause equally small rate of delirium in older adults with mood disorders

• Estrogen replacement therapy in postmenopausal women: evidence, practice and communication

  Mamdani MM, Tu K. J Womens Heal. 2000; 1(3):293-300.

• A demonstration project of a multi-component educational intervention to improve integrated post-fracture osteoporosis care in five rural communities in Ontario, Canada

  Jaglal SB, Hawker G, Bansod V, Salbach NM, Zwarenstein M, Carroll J, Brooks D, Cameron C, Bogoch E, Jaakkimainen L, Kreder H. Osteoporos Int. 2009; 20(2):265-74. Epub 2008 Jun 3.

• Low-trauma fractures and bone mineral density testing in adults with and without intellectual and developmental disabilities: a population study

  Balogh R, Wood J, Dobranowski K, Lin E, Wilton A, Jaglal SB, Gemmill M, Lunsky Y. Osteoporos Int. 2017; 28(2):727-32.

• Impact of a change in physician reimbursement on bone mineral density testing in Ontario: a population-based study

  Jaglal S, Hawker G, Croxford R, Cameron C, Schott AM, Munce S, Allin S. CMAJ Open. 2014; 2(2):E45–50. Epub 2014 Mar 31.

• Fracture types and risk factors in men with prostate cancer on androgen deprivation therapy: a matched cohort study of 19,079 men

  Alibhai SM, Duong-Hua M, Cheung AM, Sutradhar R, Warde P, Fleshner NE, Paszat L. J Urol. 2010; 184(3):918-23.

• Direct health-care costs attributed to hip fractures among seniors: a matched cohort study

  Nikitovic M, Wodchis WP, Krahn MD, Cadarette SM. Osteoporos Int. 2013; 24(2):659-69. Epub 2012 Jun 27.

• Population trends in BMD testing, treatment, and hip and wrist fracture rates: are the hip fracture projections wrong?

  Jaglal SB, Weller I, Mamdani M, Hawker G, Kreder H, Jaakkimainen L, Adachi JD. J Bone Miner Res. 2005; 20(6):898-905. Epub 2004 Dec 20.

• May 2018

  September 2018 IPDLN Conference in Banff

  Infographics

  • Food insecurity more than doubles the risk of developing type 2 diabetes
  • Happiness linked to future health care costs
  • People with diabetes at increased risk for preventable complications after cancer diagnosis
  • Study identifies red flags for frontline providers when treating infants with bronchiolitis

  ICES in the News

  • Rates of whooping cough in Ontario much higher than previously thought
  • Nearly a quarter of all Ontarians newly prescribed opioids received a daily dose exceeding clinical guidelines
  • Study finds no link between HPV vaccination and risk of autoimmune disorders

  You may also be interested in...

  • A population-based study of the risk of osteoporosis and fracture with dutasteride and finasteride
  • Unlocking First Nations health information through data linkage
  • Neighbourhood socioeconomic position and risks of major chronic diseases and all-cause mortality: a quasi-experimental study
  • Benchmarking time to initiation of end-of-life homecare nursing: a population-based cancer cohort study in regions across Canada
  • Factors associated with imaging in patients with early breast cancer after initial treatment
  • Association of clinical and economic outcomes with permanent pacemaker implantation after transcatheter aortic valve replacement

• Bisphosphonate use and the risk of subtrochanteric or femoral shaft fractures in older women

  Park-Wyllie LY, Mamdani MM, Juurlink DN, Hawker GA, Gunraj N, Austin PC, Weiler PJ, Whelan DB, Laupacis A. JAMA. 2011; 305(8):783-9.

• Examining exposure misclassification of oral bisphosphonate therapy and the associated fracture risk: a cohort study

  Burden AM, Gruneir A, Paterson JM, Cadarette SM. Adv Pharmacoepidemiol Drug Saf. 2015; 4:4.

• Uptake and characteristics of zoledronic acid and denosumab patients and physicians in Ontario, Canada: impact of drug formulary access

  Burden AM, Tadrous M, Calzavara A, Cadarette SM. Osteoporos Int. 2015; 26(5):1525-33. Epub 2015 Jan 21.

• Denosumab utilization among older adults in Ontario: patient characteristics, persistence with therapy, and return to therapy after an extended gap

  Ban JK, Hao BB, McCarthy L, Guilcher SJT, Cadarette SM. Osteoporos Int. 2019; 30(9):1865-72. Epub 2019 Jul 17. DOI: https://doi.org/10.1007/s00198-019-05051-1

• Patterns of use of the bone mineral density test in Ontario, 1992-1998

  Jaglal SB, McIsaac WJ, Hawker G, Jaakkimainen L, Cadarette SM, Chan BT. CMAJ. 2000; 163(9):1139-43.

• From pharmaco-therapy to pharmaco-prevention: trends in prescribing to older adults in Ontario, Canada, 1997-2006

  Bajcar JM, Wang L, Moineddin R, Nie JX, Tracy CS, Upshur RE. BMC Fam Pract. 2010; 11:75.

• Risk of fractures after stroke: results from the Ontario Stroke Registry

  Kapral MK, Fang J, Alibhai SM, Cram PM, Cheung AM, Casaubon LK, Prager M, Stamplecoski M, Rashkovan B, Austin PC. Neurology. 2017; 88(1):57-64. Epub 2016 Nov 23.

• Bayesian synthesis using prior information on fracture risk from randomized trials to analyze post-market data

  John-Baptiste A, Becker T, Fung K, Lipscombe LL, Austin PC, Anderson GM. J Clin Epidemiol. 2018; 101:79-86. Epub 2018 Jun 4.

• Denosumab and breast cancer risk in postmenopausal women: a population-based cohort study

  Giannakeas V, Cadarette SM, Ban JK, Lipscombe L, Narod SA, Kotsopoulos J. Br J Cancer. 2018; 119(11):1421-7. Epub 2018 Nov 13.

• Risk of osteoporotic fractures with angiotensin II receptor blockers versus angiotensin converting-enzyme inhibitors in hypertensive community-dwelling elderly

  Butt DA, Mamdani M, Gomes T, Lix L, Lu H, Tu K; on behalf of the Hypertension Outcome Surveillance Team. J Bone Miner Res. 2014; 29(11):2483-8. Epub 2014 May 7.

• Assessing methods for measurement of clinical outcomes and quality of care in primary care practices

  Green ME, Hogg W, Savage C, Johnston S, Russell G, Jaakkimainen RL, Glazier RH, Barnsley J, Birtwhistle R. BMC Health Serv Res. 2012; 12:214. Epub 2012 Jul 23.

• Patterns of care among patients referred to rheumatologists in Ontario, Canada

  Widdifield J, Tu K, Thorne JC, Bombardier C, Paterson JM, Jaakkimainen RL, Wing L, Butt DA, Ivers N, Hofstetter C, Lyddiatt A, Ahluwalia V, Bernatsky S. Arthritis Care Res (Hoboken). 2017; 69(1):104-14. Epub 2016 Nov 16.

• Effectiveness of oral bisphosphonates in reducing fracture risk among oral glucocorticoid users: three matched cohort analyses

  Amiche MA, Levesque LE, Gomes T, Adachi JD, Cadarette SM. J Bone Miner Res. 2018; 33(3):419-29. Epub 2017 Oct 25.

• Health care costs for prostate cancer patients receiving androgen deprivation therapy: treatment and adverse events

  Krahn MD, Bremner KE, Luo J, Alibhai SM. Curr Oncol. 2014; 21(3):e457-65.

• Patterns of use for brand-name versus generic oral bisphosphonate drugs in Ontario over a 13-year period: a descriptive study

  Fraser LA, Albaum JM, Tadrous M, Burden AM, Shariff SZ, Cadarette SM. CMAJ Open. 2015; 3(1):E91-96.

• «
• 1
• 2
• »